SEC Form 4 · accession 0001209191-19-005421
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin C Tang
Director · 10% Owner
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 6:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.99 | Jan 23, 2019 | A | 12,000 | A | — | Jan 23, 2029 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1The stock options vest and become exercisable on January 23, 2020, subject to the Reporting Person's continued service to the Issuer through such date.